Industry Risks and Compliance Pressures for Medical Device & Diagnostic Companies
Medical device and diagnostic companies operate at the intersection of science, regulation, and patient safety. Compliance failures in this field do not stay hidden for long. DEA oversight, FDA scrutiny, and NABP accreditation all offer constant visibility, leaving no room for uncertainty.
Companies in this space face unique risks tied to controlled material handling and regulated distribution:
- DEA Audits and Inspections: Surprise visits can interrupt manufacturing and test schedules without warning.
- Recordkeeping Gaps: Errors in tracking raw materials or product movement expose the organization to enforcement risk.
- Diversion Exposure: Research and testing environments often involve multiple touchpoints where controlled substances may be mishandled or misplaced.
- Penalties and Enforcement Actions: Financial loss, legal action, and reputational damage can follow when compliance programs lack structure or accountability